Cambridge Technologies is proud to bring a new tool in the fight against papillomas (warts) in cattle. This vaccine, which is currently conditionally licensed by the USDA, is the only wart vaccine on the market with consistent availability, backed by science demonstrating strong immune response and protection against challenge.

Our vaccine is indicated for the vaccination of cattle against warts (papillomas). Product is to be administered in a series of two 2mL doses, given subcutaneously 3 weeks apart.